Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981 Sep;45(3):504-13.

Relative ability to provide help: an explanation for Con A-induced suppression

Relative ability to provide help: an explanation for Con A-induced suppression

J Farrant et al. Clin Exp Immunol. 1981 Sep.

Abstract

Concanavalin A (Con A) induced suppression of human peripheral lymphocytes has been studied in vitro at different cell concentrations using a 20 microliters inverted Terasaki plate culture system in which the uptake of 3H-thymidine was measured. Conventional assessment of suppression relates the response of cells to Con A in the presence of Con A-pretreated autologous cells, with the response of cells preincubated without Con A (control cells). The level of suppression so calculated was affected both by serum-related high background counts and by autologous stimulation of responding cells by mitomycin-treated Con A-pretreated cells. The high background was largely removed by the use of serum-free Iscove's medium. The data involving different cell concentrations and periods of cultivation indicate that the assessment of suppression is inadequate. Both Con A-pretreated and control cells are shown to 'help' the response of autologous responder cells to added soluble Con A. When the help by Con A-treated cells is less marked than that by control cells, apparent suppression is seen since the control cell provide the conventional baseline from which suppression is judged. After longer periods of cultivation the Con A-pretreated cells increased responses more than did the control cells leading to apparent enhancement.

PubMed Disclaimer

References

    1. J Exp Med. 1972 Dec 1;136(6):1445-60 - PubMed
    1. J Immunol Methods. 1979;27(3):219-23 - PubMed
    1. J Exp Med. 1976 May 1;143(5):1100-10 - PubMed
    1. Clin Exp Immunol. 1976 Oct;26(1):95-8 - PubMed
    1. J Immunol Methods. 1977;15(2):169-81 - PubMed

LinkOut - more resources